Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 citing Sidell: Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in.... (0.08 sec) 

Diabetic cardiomyopathy revisited


S Boudina, ED Abel - Circulation, 2007 - Am Heart Assoc
The prevalence of diabetes mellitus is growing rapidly. It is estimated that
globally the number of adults affected with diabetes will increase from 135
million in 1995 to 300 million by 2025. 1 Patients with diabetes mellitus ...
Cited by 136 - Related articles - All 5 versions

Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes

- ahajournals.org
M Scheuermann-Freestone, PL Madsen, D … - Circulation, 2003 - Am Heart Assoc
Methods and Results— We studied 21 patients with type 2 diabetes with no
evidence of coronary artery disease or impaired cardiac function, as determined
by echocardiography, and 15 age-, sex-, and body mass index-matched control ...
Cited by 131 - Related articles - All 7 versions

Endothelial function, inflammation, and prognosis in cardiovascular disease


MA Gonzalez, AP Selwyn - The American journal of medicine, 2003 - Elsevier
Endothelial dysfunction may be evaluated by means of invasive techniques, such
as coronary artery reactivity to acetylcholine, or noninvasive techniques, such
as brachial artery ultrasonography. Loss of endothelium-dependent ...
Cited by 125 - Related articles - All 9 versions

Diabetic cardiomyopathy: the search for a unifying hypothesis


IG Poornima, P Parikh, RP Shannon - Circulation research, 2006 - Am Heart Assoc
Although diabetes is recognized as a potent and prevalent risk factor for
ischemic heart disease, less is known as to whether diabetes causes an altered
cardiac phenotype independent of coronary atherosclerosis. Left ventricular ...
Cited by 114 - Related articles - All 7 versions

Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus

- adisonline.com [PDF] 
AJ Wagstaff, KL Goa - Drugs, 2002 - ingentaconnect.com
Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . 1806 1. Introduction . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1809 ...
Cited by 110 - Related articles - BL Direct - All 5 versions

Peroxisome proliferator-activated receptors: vascular and cardiac effects in hypertension

- ahajournals.org
EL Schiffrin, F Amiri, K Benkirane, M Iglarz, … - Hypertension, 2003 - Am Heart Assoc
Peroxisome proliferator-activated receptors (PPAR) are nuclear receptors acting
as transcription factors on numerous target genes after heterodimerization with
the retinoid X receptor. PPAR- and PPAR- may be activated by different ...
Cited by 109 - Related articles - BL Direct - All 8 versions

Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in …

- diabetesjournals.org
E Aasum, AD Hafstad, DL Severson, TS … - Diabetes, 2003 - Am Diabetes Assoc
Glucose and palmitate metabolism and contractile function were measured with ex
vivo perfused working hearts from control (db/+) and diabetic (db/db) female
mice at 6, 10–12, and 16–18 weeks of age. Palmitate oxidation was ...
Cited by 102 - Related articles - BL Direct - All 4 versions

Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob …


PK Mazumder, BT O'Neill, MW Roberts, J … - Diabetes, 2004 - Am Diabetes Assoc
Diabetes alters cardiac substrate metabolism. The cardiac phenotype in
insulin-resistant states has not been comprehensively characterized. The goal of
these studies was to determine whether the hearts of leptin-deficient ...
Cited by 99 - Related articles - BL Direct - All 6 versions

Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/ …


A Sivarajah, PK Chatterjee, NSA Patel, Z … - Am J Nephrol, 2003 - content.karger.com
Background/Aims: Recent evidence indicates that peroxisome-proliferator
activated receptor (PPAR) agonists protect against ischemia/reperfusion (I/R)
injury. Here we investigate the effects of the PPAR- agonists, ...
Cited by 90 - Related articles - BL Direct - All 6 versions

Peroxisome proliferator-activated receptors and cardiovascular remodeling

- physiology.org
EL Schiffrin - American Journal of Physiology- Heart and Circulatory …, 2005 - Am Physiological Soc
Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors that
heterodimerize with the retinoid X receptor and then modulate the function of
many target genes. Three PPARs are known: , / , and . The better known are ...
Cited by 85 - Related articles - All 7 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google